Objective-Mutations of signal transducer and activator of transcription 3 (STAT3) are responsible for autosomal dominant hyperimmunoglobulin E syndrome. Recently, we reported frequent vascular abnormalities, including aneurysms in these patients, and demonstrated that STAT3 inhibition promoted aneurysm in mice. The purpose of this study was to investigate the role of cell-specific STAT3 signaling in the susceptibility to aneurysm. Methods and Results-C57BL/6 wild-type mice were irradiated and repopulated with bone marrow cells isolated from either wild-type mice or from mice with defective STAT3 signaling as a result of overexpression of suppressor of cytokine signaling 3 (SOCS3-Tg mice). Mice were then subjected to a validated model of abdominal aortic aneurysm induced by angiotensin II infusion for 28 days, along with repetitive injections of a neutralizing antitransforming growth factor-β antibody. We found that overexpression of SOCS3 in bone marrow-derived cells significantly increased aneurysm severity (P=0.04). In contrast, overexpression of SOCS3 in the vessel wall had no effect on the disease process. Surprisingly, deletion of STAT3 signaling in macrophages did not affect aneurysm development. Interestingly, however, defective STAT3 signaling in SOCS3-Tg T cells markedly increased aneurysm severity (P=0.01) and mortality from aneurysm rupture (P=0.008). Overexpression of SOCS3 in T cells significantly decreased interleukin-17 production (P<0.0001) and was associated with a reduction of its plasma levels (P=0.02).
A bdominal aortic aneurysm (AAA) is an age-associated disease with increasing incidence and considerable consequences on morbidity and mortality. 1 Deficiency of signal transducer and activator of transcription 3 (STAT3) is a rare primary immunodeficiency that is referred to as an autosomal dominant hyperimmunoglobulin E syndrome, caused by mutations in several domains of STAT3. 2 These patients display defective STAT3 signaling, characterized by recurrent bacterial and fungal infections, connective tissue abnormalities, hyperimmunoglobulin E, and Th17 lymphopenia. 3, 4 We recently studied 36 autosomal dominant hyperimmunoglobulin E syndrome STAT3-deficient patients and reported the presence of peripheral and brain arterial abnormalities, mainly ectasia and aneurysms in 84% of the patients, suggesting involvement of STAT3 signaling in aneurysm formation. 5 We also showed that mice with overexpression of suppressor of cytokine signaling 3 (SOCS3), which exhibit reduced STAT3 phosphorylation and activation, were highly susceptible to aneurysm formation and rupture in response to angiotensin II (Ang II) infusion and administration of a neutralizing antitransforming growth factor (TGF)-β antibody. 5 However, the mechanisms and the specific cell type(s) responsible for the vascular phenotype remained to be identified. In this study, we examined the consequences of defective STAT3 signaling in specific cell types on the susceptibility to aneurysm formation and rupture.
Materials and Methods
Details of Methods can be found in the online-only Data Supplement. We used mice with genetic overexpression of SOCS3 or cell-specific deletion of STAT3. AAA was induced by subcutaneous infusion of Ang II along with systemic neutralization of TGF-β.
Results

Disruption of STAT3 Signaling in Bone Marrow-Derived Cells Aggravates AAA
To induce severe AAA, mice were infused with Ang II and were repetitively injected with anti-TGF-β antibody for 28 days, as previously described. 5, 6 As depicted in Figure 1A , repopulation of C57BL/6 mice with SOCS3-Tg bone marrow increased the severity of AAA (P=0.04). Aneurysm formation was associated with accumulation of macrophages and T lymphocytes within the adventitia and their infiltration within the media ( Figure IA and IB in the online-only Data Supplement). Also, elastin elongation and degradation were observed in advanced aneurysms ( Figure IIC in the online-only Data Supplement). Because STAT3 signaling is known to control Th17 development, 3, 4 we examined cytokine production by spleen lymphocytes and observed a marked reduction of intracellular interleukin (IL)-17 staining (P=0.04; Figure 1B ), but no change in interferon-γ expression (P=0.34; Figure 1C ) in mice reconstituted with SOCS3-Tg bone marrow. In contrast, Th17 development and aneurysm severity were not altered in SOCS3-Tg mice reconstituted with wild-type bone marrow
Figure 1. Overexpression of suppressor of cytokine signaling 3 (SOCS3) in bone marrow-derived cells increases aneurysm severity.
A-C, Lethally irradiated (9.5 Gy) wild-type (WT) mice were reconstituted with bone marrow from either WT (WT→WT) or SOCS3-Tg (SOCS3-Tg→WT) mice. After 3 weeks of recovery, mice were treated with angiotensin (Ang) II + antitransforming growth factor (TGF)-β and euthanized after 28 days (Methods in the online-only Data Supplement). A, Classification of aortic aneurysms in the 2 groups of mice as described in the Methods in the online-only Data Supplement (increasing severity from stage 0= no aneurysm to stage IV= aneurysm rupture). B and C, Representative examples and quantitative analysis of flow cytometry-based intracellular staining of interleukin (IL)-17 (B) and interferon (IFN)-γ (C) gated on lymphocytes T in the 2 groups of mice (WT→WT, n=7; SOCS3-Tg→WT, n=5). D and E, Lethally irradiated WT (WT→WT) or SOCS3-Tg (WT→SOCS3-Tg) mice were reconstituted with bone marrow from WT mice. After 3 weeks of recovery, mice were treated with Ang II + anti-TGF-β and euthanized after 28 days. D, Quantitative analysis of intracellular staining of IFNγ and IL-17 gated on lymphocytes (WT→WT, n=5; WT→SOCS3-Tg, n=5). E, Classification of aortic aneurysms in the 2 groups of mice as described in the Methods in the online-only Data Supplement. Results are mean±SEM. **P<0.01.
( Figure 1D and 1E). These results suggest that SOCS3/STAT3 signaling in vascular cells is dispensable for AAA and identify an important contribution of STAT3/SOCS3 signaling in bone marrow-derived cells to AAA.
STAT3 Signaling in Macrophages and Neutrophils Is Dispensable for AAA Formation
Macrophages and neutrophils contribute to AAA. However, to our surprise, mice with selective deletion of STAT3 in macrophages and neutrophils (STAT3 flox/flox /LysM-Cre) did not show significant alteration of disease severity in comparison with control STAT3 flox/flox mice ( Figure II in the online-only Data Supplement). This result clearly indicates that STAT3 signaling in macrophages and neutrophils is dispensable for AAA development.
Alteration of STAT3 Signaling in T Cells Impacts AAA Formation and Severity
T helper cell responses have been shown to contribute to aneurysm development. 7, 8 We therefore addressed the contribution of SOCS3/STAT3 signaling in T cells to AAA formation.
Spleen CD4 + T cells were isolated from either wild-type or SOCS3-Tg mice and were used in an adoptive transfer model to reconstitute Rag1 −/− mice. SOCS3-Tg CD4 + T cells showed altered STAT3 phosphorylation (Figure 2A ), no change in IL-4 ( Figure 2B ) but reduced interferon-γ production (P=0.01), and an inability to produce IL-17 ( Figure 2B ). In addition, reconstitution of Rag1 −/− mice with SOCS3-Tg CD4 + T cells was associated with reduced plasma IL-17 levels (P=0.02) compared with the transfer of SOCS3 +/+ CD4 + T cells ( Figure 2C ). This decrease of IL-17 production is specific to the model because Th17 differentiation at basal state in SOCS3-Tg CD4 + cells is not altered compared with WT cells ( Figure III in the online-only Data Supplement). Interestingly, adoptive transfer of SOCS3-Tg CD4 + T cells in Rag1 −/− mice markedly increased the susceptibility of these mice to AAA compared with the transfer of SOCS3 +/+ CD4 + T cells as shown by increased aneurysm incidence, severity (P=0.01; Figure 2D and 2E) , and increased mortality from aneurysm rupture (P=0.008; Figure  2F ). Of note, repopulation of C57BL/6 mice with IL-17 −/− bone marrow increased the severity of AAA (P=0.08; Figure  IV 
Discussion
In this study, we investigated the role of cell type-specific SOCS3/STAT3 signaling in aneurysm development. Unexpectedly, inhibition of STAT3 signaling in vascular and myeloid cells did not alter mice susceptibility to AAA. We therefore considered a role for T cells. A review of the literature indicated that their role in vascular aneurysm Figure 2 . Overexpression of suppressor of cytokine signaling 3 (SOCS3) in T cells promotes aneurysm formation. A, Representative flow cytometry analysis of CD4 + wild-type (WT) and CD4 + SOCS3-Tg cells isolated from the 2 groups of mice and activated with interleukin (IL)-6 (100 ng/mL) for 15 minutes. B, Enzyme-linked immunosorbent assay of cytokine production in splenic CD4 + cells isolated from the 2 groups of mice after activation with coated anti-CD3 and anti-CD28 for 48 h. Results are mean±SEM, n=3 independent repeats per group. IFN indicates interferon; N.D., not detected. C, Plasma levels of IL-17A in Rag1 −/− mice injected with either CD4 + WT or CD4 + SOCS3-Tg cells and treated with angiotensin (Ang) II + antitransforming growth factor (TGF)-β (for 5 days). Results mean±SEM, n=4 independent mice per group. Photographs (D), classification of aortic aneurysms (E), and Kaplan-Meier curves of survival free from aneurysm rupture (F) in Rag1 −/− mice injected with either CD4 + WT (n=10) or CD4 + SOCS3-Tg (n=9) and treated with Ang II + anti-TGF-β for 28 days, *P<0.05, ***P<0.001. was still debated. [6] [7] [8] [9] Th1 responses have been shown to be pathogenic in calcium chloride-induced aneurysm formation, 7 whereas Th2-mediated immunity contributed to aneurysms in allografted aortas. 8 In the Ang II model, lymphocyte deficiency under a hypercholesterolemic Apoe −/− /Rag −/− background did not significantly alter aneurysm development. 9 In contrast, we have previously observed a significant protection from the disease in normocholestomic Rag −/− mice using a more severe aneurysm model involving neutralization of TGF-β activity on top of Ang II infusion. 6 It was therefore remarkable that the selective transfer of CD4 + T cells exhibiting defect in STAT3 signaling in immunodeficient mice markedly aggravated aneurysms and led to fatal vascular rupture, emphasizing the critical role of T cell-specific STAT3 signaling in this disease. It should be acknowledged that although deficient STAT3 signaling is a main consequence of SOCS3 overexpression, it is not the only process controlled by SOCS3. It will be interesting to confirm our results using specific deletion of STAT3 in T cells.
The mechanisms by which STAT3 signaling in T cells play a role in aneurysm development are unknown. Collectively, our results suggest that reduced IL-17 production may contribute to enhanced vascular inflammation and increased susceptibility to aneurysms. 5 These data are supported by results from Xiong et al 7 that reported (in abstract form) a protective role of IL-23-IL17 axis in calcium chloride-induced aneursym formation (Xiong, Baxter, Experimental Biology 2010, abstract no. 751.6). Other investigators reported either a detrimental role of IL-17 deficiency (Madhur, Harrison, Experimental Biology 2010, abstract no. 589.8) or no effect in Ang II-induced AAA under hypercholesterolemic Apoe −/− background without mechanistic details. 10 Future studies should delineate more precisely the role of IL-17 and the different STAT3 signaling targets in aneurysm progression and identify the critical STAT3-related factors responsible for destructive vessel remodeling.
